NCT06939595Active, not recruitingPhase 3
A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
A Double-Blind, Randomized, Active-Controlled, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P51 and Keytruda in Combination With Platinum-Pemetrexed Chemotherapy in Patients With Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
The goal of this Phase 3 clinical trial is to compare efficacy and safety of CT-P51 and European Union (EU) approved Keytruda in combination with platinum pemetrexed chemotherapy in patients with previously untreated metastatic nsNSCLC.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 225 (actual)
- First submitted
- 21 Apr 2025
- Start date
- 30 Jan 2025
- Primary completion date
- Feb 2027
- Lead sponsor
- Celltrion
- Diseases
- Lung cancer
- NCT number
- NCT06939595
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 225
- From 30 Jan 2025 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hypersensitivity or contraindication to any component of the study drug, pemetrexed and cisplatin or carboplatin
Other
- Have predominantly squamous cell histology NSCLC.
Who the study is looking for
- Stage IV, non squamous NSCLC
- Have not received any prior systemic anti-cancer therapy for metastatic NSCLC
- Have at least 1 measurable lesion per RECIST version 1.1
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ltd "Institute of Clinical Oncology" Coordinator of this site? Confirm its status | Tbilisi | Georgia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.